NCT07217730

Healthcare Integrity & Anti-Fraud Enforcement

Enrolling by Invitation
Not specifiedAll AgesObservational
Truway Health, Inc.
~100 participants
Updated 2025-10-20 on ClinicalTrials.gov
What's tested:Validator-Governed Reform & Regulatory Escalation ProtocolCoalition-Grade Validator Dashboard Module (CVDM-1)Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Fraudulent Billing and Kickback Incidents Across Enrolled Facilities
Measured over Baseline to 12 Months Post-Validator Onboarding
Healthcare Fraud Schemes
Kickback Networks
Supply Chain Vulnerabilities
Governance Failures
Whistleblower Activation
Regulatory Escalation Pathways
Validator Oversight & DAO Governance
Public Transparency & Auditability
1 sites across 1 states
New York1
  • Gavin C Solomon, President & CEO · PRINCIPAL_INVESTIGATOR · Truway Health, Inc.

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Change in Fraudulent Billing and Kickback Incidents Across Enrolled FacilitiesBaseline to 12 Months Post-Validator Onboarding

    Description: This outcome measures the change in frequency and severity of fraudulent billing practices-including upcoding, phantom billing, and referral-based kickback schemes-across facilities enrolled in the SHA-256 Trial Protocols. Facilities are assessed using the Unified Impact Index derived from: Historical billing anomalies Validator audit results Whistleblower declarations SHA-256 hash-anchored incident reports Facilities are ranked and monitored for reform compliance, ethical standards, and onboarding validation. All scoring logic is notarized and displayed via coalition dashboards. Time Frame: Baseline to 12 Months Post-Validator Onboarding.